Introduction: Cognitive decline is one of Parkinson's disease's (PD) non-motor symptoms that is most frequently observed. Patients with PD exhibit quick cognitive decline in a variety of cognitive domains, particularly in the areas of executive functions, attention, language, mem...
Open access
Research Article10.9734/jpri/2023/v35i327467
Introduction: One of the most common non motor symptoms of Parkinson's disease (PD) is cognitive decline. Scientific evidence has demonstrated that patients with PD experience rapid cognitive decline in multiple cognitive domains, specifically executive functions, attention, visu...
Open access
Research Article10.9734/jpri/2022/v34i31A36087
Ibrahim Dighriri, Abdulrahman Hommadi, Hatim Zaeri, Rahaf Aldajany, Rahaf Alotaibi, Fai Aljuaid, Shoug Aljuaid, Abdullah Madkhali, Saleh Ghulaysi, Abeer Alanazi, Sarah Alburaidi, Amal Hamdan, Hassan Alzahrani, Razan Musharraf & Bashaier Albutaih·Journal of Pharmaceutical Research International·2021
Background: Atorvastatin is a recent HMG-COA reductase inhibitor used to treat primary hypercholesterolemia, homozygous familial hypercholesterolemia, and mixed dyslipidemias. It is also taken to prevent heart disease, including strokes and heart attacks. In addition, Atorvastati...
Open access
Research Article10.9734/jpri/2021/v33i54A33750